Cytokine Response to Antigen Stimulation of Whole Blood from Patients with Mycobacterium ulcerans Disease Compared to That from Patients with Tuberculosis

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinical and Vaccine Immunology

• Publication date

  2006-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/CVI.13.2.253-257.2006PMID 16467334PMCID PMC1391935
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytokine Responses to Stimulation of Whole Blood from Patients with Buruli Ulcer Disease in Ghana

  2005cited by this paper
• Specific Detection of Tuberculosis Infection: An Interferon-γ–based Assay Using New Antigens

  2004cited by this paper
• Differential Production of Systemic and Intralesional Gamma Interferon and Interleukin-10 in Nodular and Ulcerative Forms of Buruli Disease

  2004influential reference
• Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts.

  2004cited by this paper
• Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens.

  2004cited by this paper
• Reactivation of Tuberculosis During Immunosuppressive Treatment in a Patient with a Positive QuantiFERON®-RD1 Test

  2004cited by this paper
• Comparison of a whole-blood interferon-gamma assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection.

  2003cited by this paper
• Dynamics of cytokine generation in patients with active pulmonary tuberculosis

  2003cited by this paper
• Cytokine Profiles of Patients Infected with Mycobacterium ulcerans and Unaffected Household Contacts

  2002influential reference
• Evaluation of a whole-blood interferon-gamma release assay for the detection of Mycobacterium tuberculosis infection in 2 study populations.

  2002cited by this paper
• Protection against tuberculosis: cytokines, T cells, and macrophages

  2002cited by this paper
• Immune Response to Infection withMycobacterium ulcerans

  2001cited by this paper
• Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10.

  2001cited by this paper
• Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection.

  2001cited by this paper
• A Mycobacterium ulcerans Toxin, Mycolactone, Causes Apoptosis in Guinea Pig Ulcers and Tissue Culture Cells

  2000cited by this paper
• Depressed Interleukin-12 (IL-12), but not IL-18, Production in Response to a 30- or 32-Kilodalton Mycobacterial Antigen in Patients with Active Pulmonary Tuberculosis

  2000cited by this paper
• Sequestration of T lymphocytes to body fluids in tuberculosis: reversal of anergy following chemotherapy.

  1999cited by this paper
• Tuberculin-Purified Protein Derivative-, MPT-64-, and ESAT-6-Stimulated Gamma Interferon Responses in Medical Students before and after Mycobacterium bovis BCG Vaccination and in Patients with Tuberculosis

  1999cited by this paper
• Disease-specific ex vivo stimulation of whole blood for cytokine production: applications in the study of tuberculosis.

  1999cited by this paper
• Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection.

  1998cited by this paper
• Antigens in culture supernatant of Mycobacterium tuberculosis: epitopes defined by monoclonal and human antibodies.

  1990cited by this paper
• The production and preliminary investigation of Burulin, a new skin test reagent for Mycobacterium ulcerans infection

  1975cited by this paper
• A controlled trial of the treatment of Mycobacterium ulcerans infection with clofazimine.

  1973influential reference
• MYCOBACTERIAL SKIN ULCERS IN UGANDA: HISTOPATHOLOGICAL AND EXPERIMENTAL ASPECTS.

  1964cited by this paper

• A human model of Buruli ulcer: Provisional protocol for a Mycobacterium ulcerans controlled human infection study.

  2024cites this paper
• Mycobacterium ulcerans Disease and Host Immune Responses

  2023cites this paper
• Memory B-cells are enriched in the blood of patients with acute Buruli ulcer disease: a prospective observational study

  2023cites this paper
• T-cell responses against Mycobacterium ulcerans and Mycobacterium tuberculosis protein extracts identify children with Buruli ulcer disease.

  2022cites this paper
• Cell-mediated and serology-based tests for Mycobacterium ulcerans disease: A systematic review and meta-analysis

  2020cites this paper
• Mycolactone: More than Just a Cytotoxin

  2019cites this paper
• The Immunology of Buruli Ulcer

  2019cites this paper
• IFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with Mycobacterium ulcerans infection

  2018cites this paper
• Epidemiology of Buruli ulcer cases and a potential screening test for exposure

  2018cites this paper
• Analysis of Mycobacterium ulcerans-specific T-cell cytokines for diagnosis of Buruli ulcer disease and as potential indicator for disease progression

  2017cites this paper
• Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice

  2016cites this paper
• Manifestations cutanéomuqueuses des mycobactéries environnementales (dont Mycobacterium ulcerans)

  2016cites this paper
• Manifestaciones cutaneomucosas de las micobacterias ambientales (incluida Mycobacterium ulcerans)

  2016cites this paper
• Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease

  2015cites this paper
• Mycobacterium ulcerans and Buruli Ulcer

  2015cites this paper
• Virulence factors expressed by Mycobacterium ulcerans strains: Results of a descriptive study

  2015cites this paper
• Apoptosis in Buruli ulcer: a clinicopathological study of 45 cases

  2012cites this paper
• Effects of Chinese herbal recipes on immunity in immunosuppressive mice.

  2012cites this paper
• Acquired Immunity: Chronic Bacterial Infections

  2011cites this paper
• Antioxidants Protect Keratinocytes against M. ulcerans Mycolactone Cytotoxicity

  2010cites this paper
• Serum cytokine profile during Mycobacterium ulcerans infection (Buruli ulcer)

  2010cites this paper
• Buruli ulcer.

  2009cites this paper
• IFN-γ–Dependent Activation of Macrophages during Experimental Infections by Mycobacterium ulcerans Is Impaired by the Toxin Mycolactone

  2009cites this paper
• Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease.

  2009cites this paper
• Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans

  2009cites this paper
• Mycolactone Suppresses T Cell Responsiveness by Altering Both Early Signaling and Posttranslational Events

  2009cites this paper
• Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer.

  2009cites this paper
• Immunosuppression and treatment-associated inflammatory response in patients with Mycobacterium ulcerans infection (Buruli ulcer)

  2009cites this paper
• Approaches to improve treatment and early diagnosis of Buruli ulcer. the role of local and systemic immune responses

  2009cites this paper
• Mycolactone Inhibits Monocyte Cytokine Production by a Posttranscriptional Mechanism1

  2009cites this paper
• This information is current as Mechanism Production by a Posttranscriptional Mycolactone Inhibits Monocyte Cytokine

  2009cites this paper
• This information is current as Signaling and Posttranslational Events Responsiveness by Altering Both Early Mycolactone Suppresses T Cell

  2009cites this paper
• Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria

  2008cites this paper
• Dynamics of the Cytokine Response to Mycobacterium ulcerans during Antibiotic Treatment for M. ulcerans Disease (Buruli Ulcer) in Humans

  2008influential citation
• Antimicrobials: Z-ring Achilles' heel for MRSA

  2008cites this paper
• Mycolactone Diffuses from Mycobacterium ulcerans–Infected Tissues and Targets Mononuclear Cells in Peripheral Blood and Lymphoid Organs

  2008cites this paper
• Systemic and local interferon‐gamma production following Mycobacterium ulcerans infection

  2007cites this paper
• IL-10 Underlies Distinct Susceptibility of BALB/c and C57BL/6 Mice to Mycobacterium avium Infection and Influences Efficacy of Antibiotic Therapy1

  2007cites this paper
• Influences Efficacy of Antibiotic Therapy Infection and Mycobacterium avium BALB/c and C57BL/6 Mice to IL-10 Underlies Distinct Susceptibility of

  2007cites this paper
• Cytokine mRNA Expression in Mycobacteriam ulcerans-Infected Human Skin and Correlation with Local Inflammatory Response

  2006cites this paper
• Evidence for an Intramacrophage Growth Phase of Mycobacterium ulcerans

  2006influential citation
• Buruli ulcer: emerging from obscurity.

  2006cites this paper